---
title: "T&K: The drug registration application for Methanesulfonic Acid Safinamide Tablets has been accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257860645.md"
description: "T&K announced that its wholly-owned subsidiary Anhui T&K Pharmaceutical Co., Ltd. has received the acceptance notice for the drug registration application for Safinamide Mesylate Tablets issued by the National Medical Products Administration. This drug is a selective inhibitor of monoamine oxidase B (MAO-B) and is primarily used for the treatment of adult patients with idiopathic Parkinson's disease as an adjunct therapy to levodopa"
datetime: "2025-09-18T08:14:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257860645.md)
  - [en](https://longbridge.com/en/news/257860645.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257860645.md)
---

# T&K: The drug registration application for Methanesulfonic Acid Safinamide Tablets has been accepted

According to the Zhitong Finance APP, T&K (301263.SZ) announced that its wholly-owned subsidiary Anhui T&K Pharmaceutical Co., Ltd. recently received the "Acceptance Notice" for the domestic production drug registration application for Safinamide Mesylate Tablets issued by the National Medical Products Administration (hereinafter referred to as "NMPA"). The NMPA reviewed the drug registration application in accordance with Article 32 of the Administrative Licensing Law of the People's Republic of China and decided to accept it.

Safinamide Mesylate Tablets are a selective inhibitor of monoamine oxidase B (MAO-B), primarily used for the treatment of adult patients with idiopathic Parkinson's disease (PD) as an adjunct therapy to stable doses of levodopa (L-dopa) alone or in combination with other PD treatments for patients with mid-to-late stage fluctuations

### Related Stocks

- [301263.CN](https://longbridge.com/en/quote/301263.CN.md)

## Related News & Research

- [10:30 ETPrime IV Hydration & Wellness Named No. 809 on the 2026 Inc. 5000 List of America's Fastest-Growing Private Companies](https://longbridge.com/en/news/295814685.md)
- [FDA Issues Warning About Certain Products Containing Toxic Yellow Oleander](https://longbridge.com/en/news/295690341.md)
- [10:52 ETCosmetic Physician Partners Ranks in Top 10% of 2026 Inc. 5000 List of Fastest-Growing Private Companies](https://longbridge.com/en/news/295681753.md)
- [Volare launches share issue as Pori commercial-scale plant comes online](https://longbridge.com/en/news/295769322.md)
- [Salungano Group CEO associate buys shares worth R 2.48 million](https://longbridge.com/en/news/295666160.md)